Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): A targeted oncoprotein strikes back

N. von Bubnoff, C. Peschel, J. Duyster

Research output: Contribution to journal › Article › peer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): A targeted oncoprotein strikes back'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology